Effects of the potential lithium-mimetic, ebselen, on brain neurochemistry: a magnetic resonance spectroscopy study at 7 tesla

A Longitudinal (6-week) 3T 1H-MRS Study on the Effects of Lithium Treatment on Anterior Cingulate Cortex Metabolites in Bipolar Depression

(2015) Rodrigo Machado-Vieira et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data

(2015) Brian Shine et al.   LANCET

Effect of the Putative Lithium Mimetic Ebselen on Brain Myo-Inositol, Sleep and Emotional Processing in Humans

(2015) Nisha Singh et al.   NEUROPSYCHOPHARMACOLOGY

Could glutamate spectroscopy differentiate bipolar depression from unipolar?

(2014) Matthew J. Taylor   JOURNAL OF AFFECTIVE DISORDERS

Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways

(2014) Gajendra Kumar Azad et al.   MOLECULAR BIOLOGY REPORTS

Juvenile Antioxidant Treatment Prevents Adult Deficits in a Developmental Model of Schizophrenia

(2014) Jan-Harry Cabungcal et al.   NEURON

Altered plasma glutathione levels in bipolar disorder indicates higher oxidative stress; a possible risk factor for illness onset despite normal brain-derived neurotrophic factor (BDNF) levels

(2014) A. R. Rosa et al.   PSYCHOLOGICAL MEDICINE

Kinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitors

(2013) Ajit G. Thomas et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

A safe lithium mimetic for bipolar disorder

(2013) Nisha Singh et al.   Nature Communications

Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis

(2013) A. Cipriani et al.   BMJ-British Medical Journal

Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis

(2012) Alexandre Duarte Gigante et al.   BIPOLAR DISORDERS

Lithium toxicity profile: a systematic review and meta-analysis

(2012) Rebecca F McKnight et al.   LANCET

Region and state specific glutamate downregulation in major depressive disorder: A meta-analysis of 1H-MRS findings

(2011) J.J. Luykx et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Regional neurochemical profiles in the human brain measured by 1H MRS at 7 T using local B1 shimming

(2011) Uzay E. Emir et al.   NMR IN BIOMEDICINE

Magnetic Resonance Spectroscopy Studies of Glutamate-Related Abnormalities in Mood Disorders

(2010) Cagri Yüksel et al.   BIOLOGICAL PSYCHIATRY

Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders

(2010) Jeremy W. Gawryluk et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

The BALANCE trial – Authors' reply

(2010) John Geddes et al.   LANCET

Knockout mice in understanding the mechanism of action of lithium: Table 1

(2009) Galila Agam et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

In vivo1H NMR spectroscopy of the human brain at high magnetic fields: Metabolite quantification at 4T vs. 7T

(2009) Ivan Tkáč et al.   MAGNETIC RESONANCE IN MEDICINE

The default mode network and self-referential processes in depression

(2009) Yvette I. Sheline et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Glutathione: a novel treatment target in psychiatry

(2008) Michael Berk et al.   TRENDS IN PHARMACOLOGICAL SCIENCES